USE OF NEUROTRANSMITTER TESTING FOR PHYCHOLOGICAL ISSUES – (07-23-07)



Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort

While it’s not comforting to note that there was a drastic increase in the risk of suicide attempts in new users of antidepressants, it is comforting to note that they seemed to succeed much less frequently. Wow–where do I sign up!! What’s odd about neurological/mental disorders is that we don’t do any testing. For blood pressure, we check your pressure, give you meds or lifestyle interventions and check again. Not the same with psychological issues, despite the fact that neurotransmitter testing has been available for many years now (www.neurorelief.com) and is very reliable and easy to do.

So, when we give someone a medication that effects the way their brain works at its most fundamental level, we’re basically performing a dangerous guessing came if we don’t check neurotransmitters first.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Depression
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”